9EH Stock Overview
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Evolent Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$27.20 |
| 52 Week High | US$33.00 |
| 52 Week Low | US$22.40 |
| Beta | 1.54 |
| 1 Month Change | -8.72% |
| 3 Month Change | -0.73% |
| 1 Year Change | -14.47% |
| 3 Year Change | 53.67% |
| 5 Year Change | 128.42% |
| Change since IPO | 61.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9EH | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -2.2% | -2.5% | 0.5% |
| 1Y | -14.5% | -25.2% | 1.3% |
Price Volatility
| 9EH volatility | |
|---|---|
| 9EH Average Weekly Movement | 4.8% |
| Healthcare Services Industry Average Movement | 3.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9EH has not had significant price volatility in the past 3 months.
Volatility Over Time: 9EH's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 4,700 | Seth Blackley | www.evolent.com |
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.
Evolent Health, Inc. Fundamentals Summary
| 9EH fundamental statistics | |
|---|---|
| Market cap | €3.11b |
| Earnings (TTM) | -€132.61m |
| Revenue (TTM) | €1.83b |
1.6x
P/S Ratio-22.7x
P/E RatioIs 9EH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9EH income statement (TTM) | |
|---|---|
| Revenue | US$1.96b |
| Cost of Revenue | US$1.50b |
| Gross Profit | US$460.47m |
| Other Expenses | US$602.73m |
| Earnings | -US$142.26m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | -1.25 |
| Gross Margin | 23.45% |
| Net Profit Margin | -7.24% |
| Debt/Equity Ratio | 47.9% |
How did 9EH perform over the long term?
See historical performance and comparison